Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension
- Authors: Ivanov KP1, Mychka V.B.1, Kirillova MY.1, Chazova I.E.1, Ivanov KP1, Mychka VB1, Kirillov MJ1, Chazova IE1
-
Affiliations:
- Issue: Vol 6, No 1 (2009)
- Pages: 64-66
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33075
- DOI: https://doi.org/10.26442/SG33075
- ID: 33075
Cite item
Full Text
Abstract
About the authors
K P Ivanov
Viktoriya Borisovna Mychka
M Yu Kirillova
Irina Evgen'evna Chazova
K P Ivanov
V B Mychka
M J Kirillov
I E Chazova
References
- Чазова И.Е., Мычка В.Б. Метаболический синдром. М., 2008.
- Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996; 334: 374-81
- Filer JS. Leptin resistance and obesity. Presented at the 60 th Scientific Sessions of the american diabetes association. June 13, 2000. San-Antonio, Texas.
- Диагностика и лечение метаболического синдрома. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2007; 6(6).
- Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2008; 7(6).
Supplementary files
![](/img/style/loading.gif)